Clinical Trial

Social Feedback and Dysfunctional Risk Taking in NSSI Adolescents

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2024 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Nonsuicidal self-injury (NSSI) is defined as direct, intentional physical injury without suicidal intention. Problematic interpersonal relationships and decision-making have been demonstrated to play crucial roles in this maladaptive behavior, especially for adolescents. Accumulating evidence suggests that decision processes and risk-taking are strongly influenced by the affective state of the individual. However, whether these interactions are disrupted in NSSI adolescents has not been systematically examined. In the current study, the investigators modified one of the most widely used paradigms for measuring an individual's risk decision-making, the Balloon Analogue Risk Task (BART). The investigators combine social reward (green balloon), punishment (red balloon), and control feedback (yellow balloon), to investigate whether the NSSI adolescents have dysfunctional risk-taking behavior while facing different social outcomes. The investigators recruit one group of NSSI adolescents (n = 40) and one health control (HC) group (n = 40), to compare their risk-related decisions during the emotional BART. The investigators hypothesize that compared to HC, NSSI adolescents will show altered effects of social reward and punishment on risk-related decision-making, in particular higher risk avoidance in the context of social punishment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-04.
Status change: Not Yet Recruiting → Recruiting 2024-04-09
Trial Details
NCT Number NCT05981677
Lead Sponsor University of Electronic Science and Technology of China
Conditions Nonsuicidal Self Injury, Risk-Taking
Enrollment 80 participants
Start Date 2023-12-06
Primary Completion 2026-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2024-04-11